BIOCHEMICAL CHANGES IN HEMOLYTIC DISEASE OF THE NEWBORNS AND THEIR RELATIONSHIP WITH CLINICAL SYMPTOMATICS (literature review)

FULL TEXT:

Abstract

Complex pathophysiological changes in the maternal-placental, fetal-infant system are reflected in a number of diseases of the perinatal period, in particular, this concerns hemolytic disease of the newborn. This review article presents modern literature data on biochemical changes in hemolytic disease of the newborn and its relationship with clinical symptoms. Based on an in-depth analysis of the literature on the identification of risk factors and the mechanism of formation of the pathological process due to incompatibility of the fetus and mother by erythrocyte antigens: the Rhesus system, ABO or more rare factors with subsequent immunological conflict, objective early methods of diagnosing hemolytic disease of the newborn, it can be concluded that, to date, have not been finally resolved, a comprehensive study is required of background conditions that provoke the development of complications even with relatively low rates of hyperbilirubinemia, in particular, dyselectrolytemia and immaturity, which can be the basis for our further research.

About the Authors

List of references

Akhrarova N.A., Umarova M.S., Kosimov O.U. The role of microelement imbalance in the mother-placenta-fetus system in the birth of low birth weight children. Pediatrics. Tashkent, 2021, 1: p-29-33.

Degtyarev D.N. Diagnosis and treatment of hemolytic disease of the newborn. Draft clinical guidelines / D.N. Degtyarev, A.V. Degtyareva, N.Yu. Karpov // Neonatology. - 2015. - No. 2. - P. 87-101.

Clinical guidelines. Hemolytic disease of the newborn / edited by N.N. Volodin, D.N. Degtyarev, D.S. Kryuchko.-M. M.: GEOTAR-Media, 2019.

Pediatrics: a textbook for medical universities / edited by N.P. Shabalov. - 7th ed., corr. And add. - St. Petersburg: SpetsLit, 2019. - 943 p.

Tuychieva L.N., Akhmedova D.I. The state program "Year of a Healthy Mother and Child" is an important stage in the further improvement of children's health in Uzbekistan. J. Pediatrics. Tashkent, 2016.-№4.

Shabalov N.P. Neonatology: A textbook: in 2 volumes. M.: GEOTAR-Media, 2013

Ozherel'eva M.A. Rhesus sensitization, hemolytic disease of the fetus and newborn. Modern trends and prospects / M.A. Ozherel'eva, E.N. Kravchenko, L.V. Kuklina // Obstetrics and Gynecology.-2015.-№12.-P.16-20.

Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study / S. Sainio [et al.] // Acta Obstet. Gynecol. Scand. -2015. - Vol. 94, № 4. - P. 383-390. DOI: https://doi.org/10.1111/aogs.12590

Nandyal R.R. Hemolytic disease of the newborn // J. Hematol. Thromb. Dis. 2015. Vol. 3. P. 203–205. doi: 10.4172/2329-8790.1000203. DOI: https://doi.org/10.4172/2329-8790.1000203

Sedlak T.W., Snyder S.H. Bilirubin benefits: cellular protection by biliverdin reductase antioxidant cycle // Pediatrics. – 2004. – Vol. 113. – P. 1776-1782. DOI: https://doi.org/10.1542/peds.113.6.1776

Sameer Wagle, Hemolytic Disease of Newborn – eMedicine.com Архивная копия от 3 августа 2017 на Wayback Machine

Sarnat H.B., Sarnat M.S. Neonatal encephalopathy following fetal distress: a clinical and encephalographic study // Arch. Neurol. – 1976. – Vol. 33(10). – P. 696-705. DOI: https://doi.org/10.1001/archneur.1976.00500100030012

Sinha S., Miall L., Jardine L. Essential Neonatal Medicine. 5th ed. Chichester: Wiley; Blackwell, 2012. 388 p.

Schrader C.M., Billings A.N. False neonatal AB0 blood typing due to contamination of the cord blood // AMSRJ. 2015. Vol. 1, N 2. P. 157–162. DOI: https://doi.org/10.15422/amsrj.2015.03.008

Weiner C.P., Wenstrom K.D., Sipes S.L., Williamson R.A. Risk Factors for cordocentesis and fetal intravascular transfusion// Am J. Obstet. Gynecol.- 1991.-Vol.165.-R 1020-1025. DOI: https://doi.org/10.1016/0002-9378(91)90462-Z

Weiner C.R, Williamson R.A., Wenstrom K.D., Sipes S.L., Widness J.A., Grant S.S. et al. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment//Am J. Obstet. Gynecol.- 1991.-Vol. 165.-P. 1302-1307. DOI: https://doi.org/10.1016/S0002-9378(12)90748-6

Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: A continuing problem// Clin. Obstet. Gynecol. -1982.-VÖ1. 25.-P. 321-322. DOI: https://doi.org/10.1097/00003081-198206000-00012

Westgren M., Selbing A., Stangenberg M. Fetal Intracardiac transfusions in patients with severe rhesus isoimmunisation. Br. Med. J. -1988.- Vol. 296.-P. 885 DOI: https://doi.org/10.1136/bmj.296.6626.885

Widmann F.K. Standards for blood> banks and transfusion services// 15 th ed. Bethesda, MD: American Association of Blood Banks. 1993.- P.31-32.7

https://studbooks.net/2407412/meditsina/klinicheskie_aspekty_gemoliticheskoy_bolezni_novorozhdennogo

https://white-keys.ru/ochischenie-organizma/gemoliticheskaya-bolezn-u-novorozhdennyh-detei-gemoliticheskaya-bolezn.html

How to Cite

Abdullaeva Г. (2024). BIOCHEMICAL CHANGES IN HEMOLYTIC DISEASE OF THE NEWBORNS AND THEIR RELATIONSHIP WITH CLINICAL SYMPTOMATICS (literature review). International Journal of Scientific Pediatrics, 3(9), 736–740. https://doi.org/10.56121/2181-2926-2024-3-9-736-740
Views: 0